Cargando…

Chronic hydroxychloroquine therapy and COVID-19 outcomes: A retrospective case-control analysis

Detalles Bibliográficos
Autores principales:	Rangel, Lauren K., Shah, Payal, Lo Sicco, Kristen, Caplan, Avrom S., Femia, Alisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier on behalf of the American Academy of Dermatology, Inc. 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797175/ https://www.ncbi.nlm.nih.gov/pubmed/33440213 http://dx.doi.org/10.1016/j.jaad.2020.10.098

Ejemplares similares

Dermatologists’ Role in the Diagnosis and Management of Coronavirus Disease 2019 Coagulopathy
por: Shah, Payal, et al.
Publicado: (2020)

Urticarial dermatitis herpetiformis: A rare presentation of an uncommon disorder
por: Sally, Rachel, et al.
Publicado: (2022)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

A case of synchronous herpes zoster infection and leukocytoclastic vasculitis localized to the same dermatome
por: Shah, Payal, et al.
Publicado: (2021)

Necrolytic acral erythema in a patient with sarcoidosis
por: Shah, Payal, et al.
Publicado: (2020)

Hydroxychloroquine in a COVID-19 patient on chronic Pregabalin therapy- Is it safe?
por: Chilkoti, Geetanjali Tolia, et al.
Publicado: (2022)

Hidradenitis suppurativa is associated with iron deficiency anemia, anemia of chronic disease, and sickle cell anemia—A single-center retrospective cohort study
por: Parameswaran, Anupama, et al.
Publicado: (2021)

A case of drug reaction with eosinophilia and systemic symptoms with colitis as a presenting feature
por: Shah, Payal, et al.
Publicado: (2021)

Response to “Patient preference for cellulitis treatment: at-home care is preferred to hospital-based treatment”
por: Shaw, Katharina S., et al.
Publicado: (2020)

Reactive granulomatous dermatitis: A useful and encompassing term
por: Wanat, Karolyn Ann, et al.
Publicado: (2022)

Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities
por: Klein, Elizabeth J., et al.
Publicado: (2022)

Hydroxychloroquine for the management of chronic chikungunya arthritis
por: Nogueira, Igor Albuquerque, et al.
Publicado: (2023)

Hydroxychloroquine shortage
por: Patel, J., et al.
Publicado: (2020)

Corticosteroid use in chronic dermatologic disorders and osteoporosis
por: Lupsa, Beatrice C., et al.
Publicado: (2021)

Advances in cutaneous vasculitis research and clinical care
por: Caplan, Avrom, et al.
Publicado: (2021)

Profound leukemia cutis in a patient with relapsed T-cell acute lymphoblastic leukemia
por: Nohria, Ambika, et al.
Publicado: (2021)

Microbiomes for All
por: Muth, Theodore R., et al.
Publicado: (2020)

Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial
por: Calderón, José Meneses, et al.
Publicado: (2020)

Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
por: Sun, Xiaoxuan, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Hydroxychloroquine: is there a role in long COVID?
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Hyperpigmentation Induced by Hydroxychloroquine
por: Hamri, Laila
Publicado: (2023)

Specificity in the actions of the UBR1 ubiquitin ligase in the degradation of nuclear receptors()
por: Sultana, Rasheda, et al.
Publicado: (2013)

Understanding perceptions of hair loss in hijab-wearing women: a pilot survey study
por: Alhanshali, Lina, et al.
Publicado: (2023)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

Fixed Drug Eruption to Hydroxychloroquine
por: Swarnkar, Bhavya, et al.
Publicado: (2021)

Update on hydroxychloroquine use in pregnancy
por: Nori, Wassan, et al.
Publicado: (2023)

Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration
por: Lipner, Shari R., et al.
Publicado: (2020)

Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018)

Hydroxychloroquine prescribing habits and impact of the COVID-19 pandemic
por: Kuraitis, Drew, et al.
Publicado: (2021)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
por: Rani, Seema, et al.
Publicado: (2020)

Vitamin C deficiency in patients with acute myeloid leukemia: a case series and review of the literature
por: Milbar, Heather C., et al.
Publicado: (2023)

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study
por: Painvin, Benoit, et al.
Publicado: (2020)

Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia
por: Di Tano, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rb68cdcfhei5ikr9f7f6p2dkh9